ARTICLE | Clinical News
Alprox-TD: Began Phase III trials
September 24, 2001 7:00 AM UTC
NexMed Inc. (NEXM), Robbinsville, N.J. Product: Alprox-TD Business: Reproductive, Drug delivery Therapeutic category: Vasodilation Target: Smooth muscle cells Description: Topical formulation of alpr...